Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
47.10
-0.05 (-0.11%)
Tarsus Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative therapies for unmet medical needs in the field of ocular health
The company specializes in the discovery and commercialization of treatments aimed at addressing various eye conditions, with an emphasis on conditions that significantly impact the quality of life. Through its research and development efforts, Tarsus is working to provide patients with effective solutions that enhance vision and overall eye health, leveraging advanced scientific approaches to create novel therapeutic options.
Tarsus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (NASDAQSOFI) rose sharply during Monday’s session after the company reported better-than-expected fourth-quarter revenue.
U.S. stocks traded higher, with the Dow Jones gaining around 80 points on Friday. Shares of Synaptics Incorporated (NASDAQSYNA) rose sharply on Friday after the company reported better-than-expected quarterly financial results.
